Article Type
Changed
Mon, 11/05/2018 - 09:49
Display Headline
Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality
Article PDF
Author and Disclosure Information

Navneet S. Majhail, MBBS, MD
Department of Internal Medicine, The Cleveland Clinic

Alan E. Lichtin, MD
Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Alan E. Lichtin, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: lichtia@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 70(5)
Publications
Topics
Page Number
466-470
Sections
Author and Disclosure Information

Navneet S. Majhail, MBBS, MD
Department of Internal Medicine, The Cleveland Clinic

Alan E. Lichtin, MD
Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Alan E. Lichtin, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: lichtia@ccf.org

Author and Disclosure Information

Navneet S. Majhail, MBBS, MD
Department of Internal Medicine, The Cleveland Clinic

Alan E. Lichtin, MD
Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Alan E. Lichtin, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: lichtia@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 70(5)
Issue
Cleveland Clinic Journal of Medicine - 70(5)
Page Number
466-470
Page Number
466-470
Publications
Publications
Topics
Article Type
Display Headline
Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality
Display Headline
Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media